Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants

Pediatric Infectious Disease Journal

Volumn 24, Issue 11, 2005, Pages 966-968

  Collins, Clare L ^b   Ruggeberg, Jens U ^a   Balfour, Gail ^a   Tighe, Helen ^a   Archer, Marion ^b   Bowen Morris, Jane ^b   Diggle, Linda ^b   Borrow, Ray ^c   Balmer, Paul ^c   Buttery, Jim P ^b   Moxon, E Richard ^b   Pollard, Andrew J ^b   Heath, Paul T ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Meningococcal C conjugate vaccine; Preterm infant

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG CONJUGATION; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; PERTUSSIS; POLIOMYELITIS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TETANUS;

EID: 28044433393     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000187027.45918.6a     Document Type: Article

References (14)

1. Ramsay ME, Miller E, Ashworth LA, Coleman TJ, Rush M, Waight PA. Adverse events and antibody response to accelerated immunization in term and preterm infants. Arch Dis Child. 1995;72:230-232.
2. Bernbaum JC, Daft A, Anolik R, Samuelson J, Barkin R, Douglas S, et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr. 1985;107:184-188.
3. Kristensen K, Gyhrs A, Lausen B, Barington T, Heilmann C. Antibody response to Haemophilus influenzae type b capsular polysaccliaride conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J. 1996;15:525-529.
4. D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics. 1995;96(1 Pt 1):18-22.
5. Department of Health. Handbook of Immunisation: London, United Kingdom: Her Majesty's Stationery Office; 1996.
6. Conway S, James J, Balfour A, Smithells R. Immunization of the preterm baby. J Infect. 1993;27:143-150.
7. Kirmani KI, Lofthus G, Pichichero ME, Voloshen T, D'Angio CT. Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics. 2002;109:498-504.
8. Heath PT, Booy R, McVernon J, et al. Hib vaccination in infants born prematurely. Arch Dis Child. 2003;88:206-210.
9. MacLennan JM, Shackley F, Heath PT, et al. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial. JAMA. 2000;283:2795-2801.
10. Richmond P, Borrow R, Miller E, et al. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis. 1999;179:1569-1572.
11. Slack MH, Schapira D, Thwaites RJ, et al. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular peitassis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis. 2001;184:1617-1620.
12. Bramley JC, Hall T, Finn A, et al. Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age. Vaccine. 19:2924-2931, 2001.
13. Borrow R, Andrews N, Goldblatt D, Miller E. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun. 2001;69:1568-1573.
14. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004;364:365-367.